bpc 157 reliable source Peptide BPC-157 BPC-157 Peptide (Body Protection Compound)

Intended Use: In-vitro adipocyte and lipid metabolism research In-vivo preclinical studies with IACUC approval Growth hormone fragment biology investigation Lipolysis mechanism research Academic and institutional research only NOT Intended For: Human consumption or administration Athletic performance enhancement Therapeutic treatment or diagnosis Veterinary therapeutic use Dietary supplementation or weight management Non-research applications Safety Protocols: Standard laboratory PPE required Handle in well-ventilated areas Follow institutional biosafety guidelines Proper waste disposal per regulations Consult SDS for detailed safety information

investigational, with no approved human indication

Urgency may also develop

Tesofensine structure and classification Chemical identity: Small molecule drug (not a peptide ) Chemical name: (1R,2S)-2-(3,4-dichlorophenyl)cyclopropyl]methylamine Molecular weight: 216.11 g/mol Synthetic compound (not naturally occurring) Originally code-named NS2330 Why called "tesofensine": Generic pharmaceutical name Developed by NeuroSearch (Danish company) Initially for neurological conditions Repurposed for obesity after accidental discovery Now primarily researched for weight loss Drug classification: Triple monoamine reuptake inhibitor (TRI) Affects: Dopamine, norepinephrine, serotonin Similar mechanism to ADHD medications CNS stimulant properties Schedule classification: Unscheduled but controlled Not a peptide - why included here: Often grouped with weight loss peptides Compared to semaglutide and tirzepatide Sold by peptide vendors Used in weight loss stacks Similar goals as weight loss peptides Learn about what peptides are and how they work at SeekPeptides